Osaka, Japan, April 5, 2024 - Ono Pharmaceutical Co., Ltd. announced that it has decided changes of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers at the.
ONO PHARMA Announces Enrollment Is Complete For The First Arm Of The PROSPECT Study Of Tirabrutinib In U.S. Patients With Relapsed Or Refractory PCNSL menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ ONO Pharmaceuticals, Co., Ltd. today announced it has completed target patient enrollment of the first arm (Part A) of the PROSPECT Study, a.
/PRNewswire/ Caris Life Sciences®, a molecular science company developing and delivering technologies to revolutionize healthcare, and Ono Pharmaceutical Co..
Caris Life Sciences and Ono Pharmaceutical Announce Strategic Collaboration Leveraging Caris' Novel, Blood-Based cNAS Molecular Profiling Assay Across Several Ono Clinical Studies - read this article along with other careers information, tips and advice on BioSpace